v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
CURRENT ASSETS:    
Cash $ 238,245 $ 255,298
Accounts receivable, net 269,749
Inventory, net 217,338 197,355
Prepaid expenses and other current assets 1,479 199,344
TOTAL CURRENT ASSETS 457,062 921,746
Property and equipment, net   0
Intangible assets, net 2,208,663 2,376,158
Other long term assets 0 0
Long term deposits 16,480 16,932
Operating lease right-of-use assets - net 0 0
Goodwill 467,409 467,409
Intercompany 0 0
TOTAL ASSETS 3,149,614 3,782,245
CURRENT LIABILITIES:    
Accounts payable and accrued expenses 5,410,261 4,251,391
Notes payable 2,336,554 2,046,001
Convertible debentures, net of discount 1,825,645 1,769,583
Deferred revenues 171,485 1,463
Factoring liability 843,068 673,611
Derivative liability 0 0
TOTAL CURRENT LIABILITIES 10,587,013 8,742,049
Notes payable - Long term 0 0
Operating lease liabilities - noncurrent 0 0
Other long term liabilities 0 0
TOTAL LIABILITIES 10,587,013 8,742,049
COMMITMENTS AND CONTINGENCIES (Note 12) 267,000 267,000
STOCKHOLDERS' EQUITY    
Common stock - $0.001 par value; 1,500,000,000 shares authorized; 425,980,711 and 135,756,053 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively 425,981 135,756
Additional paid in capital 27,632,897 26,357,397
Accumulated other comprehensive loss (139,757) (146,277)
Accumulated deficit (34,877,757) (30,831,052)
Stemtech Corporation shareholders’ deficit (6,958,636) (4,484,176)
Non-controlling interest in subsidiaries (745,763) (742,628)
Net loss 0 0
TOTAL STOCKHOLDERS EQUITY (7,704,399) (5,226,804)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,149,614 $ 3,782,245